ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 543 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $84,853 | -99.2% | 1,253 | -99.1% | 0.00% | -98.9% |
Q2 2023 | $10,397,045 | -1.3% | 145,271 | -4.3% | 0.09% | -10.8% |
Q1 2023 | $10,538,312 | -14.7% | 151,827 | -16.7% | 0.10% | -20.9% |
Q4 2022 | $12,359,126 | -99.9% | 182,288 | -3.3% | 0.13% | +14.2% |
Q3 2022 | $10,341,618,000 | +82329.6% | 188,578 | -0.7% | 0.11% | -8.9% |
Q2 2022 | $12,546,000 | -4.7% | 189,883 | -4.3% | 0.12% | +21.6% |
Q1 2022 | $13,164,000 | -43.6% | 198,437 | -50.4% | 0.10% | +18.6% |
Q4 2021 | $23,320,000 | +90.7% | 400,336 | +96.7% | 0.09% | -32.3% |
Q3 2021 | $12,226,000 | -56.7% | 203,558 | -13.4% | 0.13% | -59.7% |
Q2 2021 | $28,211,000 | +21.4% | 235,189 | +1.2% | 0.32% | +5.7% |
Q1 2021 | $23,242,000 | +2.0% | 232,447 | +2.2% | 0.30% | -3.9% |
Q4 2020 | $22,780,000 | -7.4% | 227,538 | +1.2% | 0.31% | -16.4% |
Q3 2020 | $24,590,000 | +3.2% | 224,910 | -1.8% | 0.37% | -7.0% |
Q2 2020 | $23,824,000 | +14.9% | 228,968 | -1.2% | 0.40% | -6.6% |
Q1 2020 | $20,731,000 | -11.9% | 231,691 | -0.8% | 0.43% | +4.7% |
Q4 2019 | $23,538,000 | +13.3% | 233,570 | +0.6% | 0.41% | +3.6% |
Q3 2019 | $20,778,000 | +17.3% | 232,212 | +7.4% | 0.39% | +20.9% |
Q2 2019 | $17,713,000 | -8.3% | 216,186 | -10.5% | 0.33% | -12.1% |
Q1 2019 | $19,318,000 | -6.4% | 241,653 | -12.4% | 0.37% | -12.1% |
Q4 2018 | $20,642,000 | -5.2% | 275,968 | -1.5% | 0.42% | +4.7% |
Q3 2018 | $21,777,000 | +13.3% | 280,050 | +1.1% | 0.40% | +6.6% |
Q2 2018 | $19,219,000 | +0.1% | 277,120 | -0.9% | 0.38% | -6.4% |
Q1 2018 | $19,207,000 | +4.2% | 279,684 | +5.2% | 0.40% | +9.8% |
Q4 2017 | $18,426,000 | +3.5% | 265,979 | -0.7% | 0.37% | -8.7% |
Q3 2017 | $17,810,000 | -0.9% | 267,899 | -0.6% | 0.40% | -5.6% |
Q2 2017 | $17,972,000 | +8.5% | 269,447 | -0.0% | 0.43% | +4.4% |
Q1 2017 | $16,558,000 | +120.3% | 269,557 | -2.0% | 0.41% | +111.9% |
Q4 2016 | $7,515,000 | -20.6% | 275,077 | -4.4% | 0.19% | -20.9% |
Q3 2016 | $9,460,000 | +11.3% | 287,877 | +2.3% | 0.24% | +7.5% |
Q2 2016 | $8,496,000 | – | 281,430 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |